Dr. Myongsei Sohn was Elected as the New Chairman of the Board of Directors, RIGHT Fund
Interview: “SK Bioscience is Developing a Cost-Effective HAV Vaccine on a Small-Footprint, Low-Cost Vaccine Manufacturing Platform”
2020년 November 30일
Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Korea’s Advanced Medical Technology Becomes Now the Hope of Developing Countries”
2021년 January 1일
